within Pharmacolibrary.Drugs.ATC.A;

model A07EA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.89,
    Cl             = 0.00025833333333333334,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.037,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.021666666666666667,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A07EA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Hydrocortisone is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties, used primarily to treat conditions such as adrenal insufficiency, inflammation, allergic reactions, and certain autoimmune disorders. It is approved for clinical use today in various forms (oral, intravenous, topical, rectal) depending on the therapeutic indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from data in healthy adult volunteers after single oral dosing.</p><h4>References</h4><ol><li><p>Czock, D, et al., &amp; Häussler, U (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. <i>Clinical pharmacokinetics</i> 44(1) 61–98. DOI:<a href=\"https://doi.org/10.2165/00003088-200544010-00003\">10.2165/00003088-200544010-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15634032/\">https://pubmed.ncbi.nlm.nih.gov/15634032</a></p></li><li><p>Leung, AKC, &amp; Barankin, B (2017). Herpes Labialis: An Update. <i>Recent patents on inflammation &amp; allergy drug discovery</i> 11(2) 107–113. DOI:<a href=\"https://doi.org/10.2174/1872213X11666171003151717\">10.2174/1872213X11666171003151717</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28971780/\">https://pubmed.ncbi.nlm.nih.gov/28971780</a></p></li><li><p>Derendorf, H, et al., &amp; Krieg, M (1991). Pharmacokinetics and oral bioavailability of hydrocortisone. <i>Journal of clinical pharmacology</i> 31(5) 473–476. DOI:<a href=\"https://doi.org/10.1002/j.1552-4604.1991.tb01906.x\">10.1002/j.1552-4604.1991.tb01906.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2050835/\">https://pubmed.ncbi.nlm.nih.gov/2050835</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A07EA02;
